![Juan Sanchez](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Juan Sanchez
Directeur/Membre du Conseil chez
NUVECTIS PHARMA, INC.
Fortune : 1 M $ au 31/05/2026
Profil
Juan F.
Sanchez is the founder of Intra-Cellular Therapies, Inc. Dr. Sanchez is currently an Independent Director at Nuvectis Pharma, Inc. starting in 2025.
Former positions include Principal at Bristol Myers Squibb Co., Research Analyst at Punk Ziegel & Co., Vice President and Vice President-Healthcare Equity Research at Ladenburg Thalmann & Co., Inc. (Broker) from 2008 to 2014, and VP-Communications & Investor Relations at Intra-Cellular Therapies, Inc. Education includes a doctorate from Pontificia Universidad Javeriana in 1994, an MBA from Universidad de Los Andes in 1999, and a graduate degree from The Trustees of Columbia University in The City of New York in 2001.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
NUVECTIS PHARMA, INC. 0,43 % | 11/06/2026 | 113 795 ( 0,43 % ) | 1 M $ | 31/05/2026 |
Postes actifs de Juan Sanchez
| Sociétés | Poste | Début |
|---|---|---|
| NUVECTIS PHARMA, INC. | Directeur/Membre du Conseil | 25/09/2025 |
Anciens postes connus de Juan Sanchez
| Sociétés | Poste | Fin |
|---|---|---|
Ladenburg Thalmann & Co., Inc. (Broker)
 Ladenburg Thalmann & Co., Inc. (Broker) Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 01/03/2014 |
Ladenburg Thalmann & Co., Inc.
 Ladenburg Thalmann & Co., Inc. Regional BanksFinance Provides investment baking, wealth management and brokerage services | Corporate Officer/Principal | 01/01/2014 |
Punk Ziegel & Co.
 Punk Ziegel & Co. Investment Banks/BrokersFinance Provides broker dealer services, investment banking and research services | Analyst-Equity | 01/05/2008 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/11/2003 |
| INTRA-CELLULAR THERAPIES, INC. | Fondateur | - |
Formation de Juan Sanchez
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
96
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Punk Ziegel & Co.
Punk Ziegel & Co. Investment Banks/BrokersFinance Provides broker dealer services, investment banking and research services | Finance |
Ladenburg Thalmann & Co., Inc. (Broker)
Ladenburg Thalmann & Co., Inc. (Broker) Investment Banks/BrokersFinance Provides brokerage services | Finance |
The Trustees of Columbia University in The City of New York
 The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ladenburg Thalmann & Co., Inc.
Ladenburg Thalmann & Co., Inc. Regional BanksFinance Provides investment baking, wealth management and brokerage services | Finance |
Universidad de Los Andes
 Universidad de Los Andes Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pontificia Universidad Javeriana
 Pontificia Universidad Javeriana Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Intra-Cellular Therapies, Inc.
 Intra-Cellular Therapies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes small molecule drugs to treat neuropsychiatric and neurological disorders | Health Technology |
Nuvectis Pharma, Inc.
 Nuvectis Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops medicines for treatment of cancer | Health Technology |
